This roundtable focuses on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders.

This roundtable focuses on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders.

This roundtable focuses on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders.

Take a tour of our Singapore central laboratory and BioA services with heightened synergy, streamlining our processes to enable faster turnaround time for early phase trials within the APAC region.

This webinar presents a general survey of the current notable biomarkers for Alzheimer's disease and where each may fit within the Alzheimer's diagnostic landscape.

Adoptive cell therapies have shown great promise in treating certain cancers. As more and more adoptive cell therapies move toward regulatory approval, robust analytical testing and biomarker identification will be key to delivering the full potential of these life-changing treatments.

As the landscape of cell therapy continues to evolve, so are the tools to assess the efficacy of cell therapy in the preclinical space.

KoBIA, South Korea conducted a webinar on "Advancing Cell and Gene Therapy: Global Challenges, Trends and AI Innovations" where our key speaker Dr. Maryland Franklin, VP and enterprise head of cell and gene therapy, discussed key challenges and lab solutions in global cell and gene therapy trials.

New drug modalities continue to accelerate beyond therapeutic proteins and into cellular and molecular

In this webinar, subject matter experts from Labcorp and Fortrea share their experience with ADME and human AME studies including why the studies are required, regulatory and scientific requirements, radiosynthesis and pharmacy considerations, clinical considerations and the benefits of an integrated approach.